Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -7.77% is 31% below its 5-year average of -5.95%, near the low end of its 5-year range (-10.14%–0.29%).
1.58% above its 12-month average of -7.89%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2026 (2026-06-30): -1.40%.
RETURN ON ASSETS (ROA)
-7.77%
RETURN ON ASSETS (ROA) AVG TTM
-7.89%
RETURN ON ASSETS (ROA) AVG 3Y
-5.07%
RETURN ON ASSETS (ROA) AVG 5Y
-5.95%
RETURN ON ASSETS (ROA) AVG 10Y
-10.13%
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+1.58%
CURRENT VS 3Y AVG
-53.25%
CURRENT VS 5Y AVG
-30.62%
CURRENT VS 10Y AVG
+23.32%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-32.24%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+75.90%
vs the sector median at left
OrthoPediatrics Corp.
Market Cap
$581.90M
Return on Assets (ROA)
-7.77%
TTM Avg
-7.89%
3Y Avg
-5.07%
5Y Avg
-5.95%
Market Cap
$578.55M
Return on Assets (ROA)
-59.22%
TTM Avg
-47.88%
3Y Avg
-51.20%
5Y Avg
-67.88%
Market Cap
$587.63M
Return on Assets (ROA)
-7.75%
TTM Avg
-4.25%
3Y Avg
-2.93%
5Y Avg
9.76%
Market Cap
$593.33M
Return on Assets (ROA)
-13.75%
TTM Avg
-12.94%
3Y Avg
-23.44%
5Y Avg
-17.36%
Market Cap
$566.03M
Return on Assets (ROA)
20.70%
TTM Avg
2.32%
3Y Avg
-24.93%
5Y Avg
-30.88%
Market Cap
$597.55M
Return on Assets (ROA)
45.55%
TTM Avg
3.15%
3Y Avg
-47.64%
5Y Avg
-20.78%
Market Cap
$560.00M
Return on Assets (ROA)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$556.75M
Return on Assets (ROA)
-20.89%
TTM Avg
7.49%
3Y Avg
-5.84%
5Y Avg
-12.60%
Market Cap
$612.16M
Return on Assets (ROA)
-23.40%
TTM Avg
-34.85%
3Y Avg
-33.75%
5Y Avg
-41.05%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OrthoPediatrics Corp. (KIDS) | $581.90M | -7.77% | -7.89% | -5.07% | -5.95% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $578.55M | -59.22% | -47.88% | -51.20% | -67.88% |
| Fulgent Genetics, Inc. (FLGT)vs › | $587.63M | -7.75% | -4.25% | -2.93% | 9.76% |
| AngioDynamics, Inc. (ANGO)vs › | $593.33M | -13.75% | -12.94% | -23.44% | -17.36% |
| CorMedix Inc. (CRMD)vs › | $566.03M | 20.70% | 2.32% | -24.93% | -30.88% |
| Ironwood Pharmaceuticals, Inc. (IRWD)vs › | $597.55M | 45.55% | 3.15% | -47.64% | -20.78% |
| MiniMed Group, Inc. (MMEDV)vs › | $560.00M | N/A | N/A | N/A | N/A |
| CytomX Therapeutics, Inc. (CTMX)vs › | $556.75M | -20.89% | 7.49% | -5.84% | -12.60% |
| Climb Bio, Inc. (CLYM)vs › | $612.16M | -23.40% | -34.85% | -33.75% | -41.05% |
| SOPHiA GENETICS S.A. (SOPH)vs › | $620.82M | -40.77% | -44.28% | -40.69% | -35.92% |
ROA
-7.8%
ROE
-11.6%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-31 | -7.80% |
| 2024-12-31 | -7.99% |
| 2023-12-31 | -4.78% |
| 2022-12-31 | 0.29% |
| 2021-12-31 | -5.27% |
| 2020-12-31 | -10.14% |
| 2019-12-31 | -7.06% |
| 2018-12-31 | -10.73% |
| 2017-12-31 | -10.85% |
| 2016-12-31 | -21.42% |
| 2015-12-31 | -25.71% |
| 2014-12-31 | -26.65% |
